Literature DB >> 399886

Lysosomes and protein degradation.

R T Dean.   

Abstract

Considerable evidence from studies with group-specific proteinase inhibitors, in particular pepstatin, the aspartic proteinase inhibitor, implicates lysosomes in turnover of endogenous cellular proteins. Recent experiments using a new group-specific inhibitor of thiol (cysteine) proteinases, Z-Phe-Ala-diazomethyl ketone, are described. Lysosomal participation is most clearly established for the degradation of long half-life proteins in situations in which turnover is accelerated because of nutritional or hormonal deficiencies. Some evidence indicating their involvement in 'basal' proteolysis is also discussed. Whether lysosomal proteolysis is selective remains to be established, and possible approaches to this question are outlined.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 399886     DOI: 10.1002/9780470720585.ch9

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  7 in total

1.  Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients.

Authors:  Clarissa Valdez; Yvette C Wong; Michael Schwake; Guojun Bu; Zbigniew K Wszolek; Dimitri Krainc
Journal:  Hum Mol Genet       Date:  2017-12-15       Impact factor: 6.150

2.  Lack of Cathepsin D in the central nervous system results in microglia and astrocyte activation and the accumulation of proteinopathy-related proteins.

Authors:  Chigure Suzuki; Junji Yamaguchi; Takahito Sanada; Juan Alejandro Oliva Trejo; Souichirou Kakuta; Masahiro Shibata; Isei Tanida; Yasuo Uchiyama
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

3.  Cathepsin D-like activity in neutrophils and monocytes.

Authors:  J Levy; G B Kolski; S D Douglas
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

4.  Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases.

Authors:  Mathieu Bourdenx; Jonathan Daniel; Emilie Genin; Federico N Soria; Mireille Blanchard-Desce; Erwan Bezard; Benjamin Dehay
Journal:  Autophagy       Date:  2016       Impact factor: 16.016

Review 5.  Cathepsin D-Managing the Delicate Balance.

Authors:  Olja Mijanovic; Anastasiia I Petushkova; Ana Brankovic; Boris Turk; Anna B Solovieva; Angelina I Nikitkina; Sergey Bolevich; Peter S Timashev; Alessandro Parodi; Andrey A Zamyatnin
Journal:  Pharmaceutics       Date:  2021-06-05       Impact factor: 6.321

6.  Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity.

Authors:  Liyan Qiao; Shusei Hamamichi; Kim A Caldwell; Guy A Caldwell; Talene A Yacoubian; Scott Wilson; Zuo-Lei Xie; Lisa D Speake; Rachael Parks; Donna Crabtree; Qiuli Liang; Stephen Crimmins; Lonnie Schneider; Yasuo Uchiyama; Takeshi Iwatsubo; Yi Zhou; Lisheng Peng; YouMing Lu; David G Standaert; Ken C Walls; John J Shacka; Kevin A Roth; Jianhua Zhang
Journal:  Mol Brain       Date:  2008-11-21       Impact factor: 4.041

7.  Haploinsufficiency of cathepsin D leads to lysosomal dysfunction and promotes cell-to-cell transmission of α-synuclein aggregates.

Authors:  E-J Bae; N Y Yang; C Lee; S Kim; H-J Lee; S-J Lee
Journal:  Cell Death Dis       Date:  2015-10-08       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.